Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4045/tidsskr.20.0377 | DOI Listing |
J Med Case Rep
October 2020
Section of Hematology, Department of Internal Medicine, Haukeland University Hospital, Bergen, Norway.
Background: The understanding of coronavirus disease 2019 (COVID-19) is rapidly evolving. Although it is primarily a respiratory illness, other manifestations, such as Guillain-Barré syndrome, immune thrombocytopenia, and immune-mediated thrombotic thrombocytopenic purpura, have been described. We present a case of a patient with hemophagocytic lymphohistiocytosis secondary to COVID-19 treated with tocilizumab with a marked biochemical improvement.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!